Midafternoon Dosing Improves Lung Function in Atopic Asthma
By Elana Gotkine HealthDay Reporter
FRIDAY, April 18, 2025 -- Midafternoon dosing with beclomethasone dipropionate is associated with better clinical outcomes in mild-to-moderate atopic asthma, according to a study published online April 15 in Thorax.
Ran Wang, Ph.D., from the NIHR Manchester Biomedical Research Centre in the United Kingdom, and colleagues conducted a randomized three-way trial to examine the impact of dosage timing for inhaled corticosteroids in participants with mild-to-moderate atopic asthma. Participants were randomly assigned to receive beclomethasone dipropionate: 400 µg once daily between 08:00 and 09:00 (ODAM); 400 µg once daily between 15:00 and 16:00 (ODPM); and 200 µg twice daily between 08:00 and 09:00 and between 20:00 and 21:00 (BD) for 28 days, with a two-week washout period between treatments.
Twenty-one of the 25 participants completed all regimens. The researchers found that compared with ODAM and BD, ODPM was superior for improving 22:00 forced expiratory volume in one second (median, +160 versus −20 and +80 ml, respectively). Better overnight (22:00 to 04:00) suppression in blood eosinophil counts was seen with ODPM compared with BD and ODAM. Improved asthma control and reduced fractional exhaled nitric oxide and serum cortisol levels were seen with all regimens, with no difference noted between regimens.
"Midafternoon dosing of inhaled beclomethasone dipropionate better improved nocturnal lung function and inflammatory biomarkers compared with the alternative dosage timings without additional adrenal suppression, hence may lead to better clinical outcomes without increasing steroid-related morbidity or costs," the authors write.
One author disclosed ties to the biopharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted April 2025
Read this next
GERD Linked to Increased Incidence of Pulmonary Disease
TUESDAY, Aug. 19, 2025 -- The presence of gastroesophageal reflux disease (GERD) is associated with an increased incidence of pulmonary diseases, but this effect may be attenuated...
Six in 10 Children With Asthma Meet Guideline Diagnostic Criteria
THURSDAY, Aug. 14, 2025 -- Roughly two-thirds of children with pediatrician-diagnosed asthma have a confirmed diagnosis in accordance with international guideline criteria...
Study IDs Inflammatory Pathways Contributing to Asthma Exacerbations in Children
TUESDAY, Aug. 12, 2025 -- Inflammatory pathways that contribute to asthma exacerbations have been identified in children with eosinophilic asthma receiving mepolizumab, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.